Close Menu

NEW YORK – Stratify Genomics said on Monday that it has partnered with PWNHealth to offer Stratify's prostate cancer genetic risk test directly to consumers with medical oversight.

Specifically, Stratify and PWNHealth will provide clinical oversight and patient support for Stratify's Prompt Personal Genetic Score (PGS) through the Stratify online portal.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.